MedTrace Logo

Evaluation of an Innovative Tuberculosis Diagnostic Test

NCT02573623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2015-10-12

No results posted yet for this study

Summary

Diagnosis of tuberculosis (TB)in young children is a challenge due to atypical non-specific symptoms, difficulty to expectorate mucus, paucibacillary nature of pulmonary TB and low sensitivity of available diagnostic tools.

This project aims at evaluating two innovative immunological methods for diagnosing of active TB among HIV-infected and uninfected children.

Conditions

Sponsors & Collaborators

  • European and Developing Countries Clinical Trials Partnership (EDCTP)

    collaborator OTHER_GOV

  • ANRS, Emerging Infectious Diseases

    lead OTHER_GOV

Principal Investigators

  • Edouard Tuaillon, MD, PhD · Université de Montpellier, France

  • Chipepo Kankasa, MD, PhD · University of Zambia, Zambia

  • Philippe Van de Perre, MD, PhD · Université de Montpellier, France

  • Nicolas Nagot, MD, PhD · Université de Montpellier, France

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-10-31
Completion
2015-12-31

Countries

  • Zambia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02573623 on ClinicalTrials.gov